These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30409739)

  • 1. Reduced levels of vasopressin, an independent mechanism in the obesity paradox in patients with chronic heart failure: Insights from the DAMOCLES study.
    Gavaldà-Manso M; Jimenez-Marrero S; Cainzos-Achirica M; Garay A; Enjuanes C; Yun S; Diez C; Gonzalez-Costello J; Tajes M; Farre N; Duran X; Comin-Colet J
    Int J Cardiol; 2019 Feb; 276():171-176. PubMed ID: 30409739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activation.
    Farré N; Aranyó J; Enjuanes C; Verdú-Rotellar JM; Ruiz S; Gonzalez-Robledo G; Meroño O; de Ramon M; Moliner P; Bruguera J; Comin-Colet J
    Int J Cardiol; 2015 Feb; 181():120-6. PubMed ID: 25497534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.
    Blanchard A; Steichen O; De Mota N; Curis E; Gauci C; Frank M; Wuerzner G; Kamenicky P; Passeron A; Azizi M; Llorens-Cortes C
    J Clin Endocrinol Metab; 2013 May; 98(5):2084-9. PubMed ID: 23515451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin levels and invasive hemodynamics in patients with advanced heart failure.
    Balling L; Goetze JP; Jung MH; Rossing K; Boesgaard S; Gustafsson F
    Biomark Med; 2018 Aug; 12(8):861-870. PubMed ID: 30058349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of obestatin and arginine vasopressin (AVP) levels in acute renal failure and acute heart failure.
    Miao XY; Li Z; Hui Z; Liu F; Zhang XW
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3277-3281. PubMed ID: 28770954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox.
    Shah R; Gayat E; Januzzi JL; Sato N; Cohen-Solal A; diSomma S; Fairman E; Harjola VP; Ishihara S; Lassus J; Maggioni A; Metra M; Mueller C; Mueller T; Parenica J; Pascual-Figal D; Peacock WF; Spinar J; van Kimmenade R; Mebazaa A;
    J Am Coll Cardiol; 2014 Mar; 63(8):778-85. PubMed ID: 24315906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The obesity paradox in heart failure: is etiology a key factor?
    Zamora E; Lupón J; de Antonio M; Urrutia A; Coll R; Díez C; Altimir S; Bayés-Genís A
    Int J Cardiol; 2013 Jul; 166(3):601-5. PubMed ID: 22204855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation effect analysis of lipoprotein levels on BMI and cardiovascular outcomes in patients with heart failure.
    Wang Y; Liu X; Wu B; Tan X; Chen L; Chu H; Zhou Z; Bao X; Xu B; Gu R
    BMC Cardiovasc Disord; 2024 Oct; 24(1):553. PubMed ID: 39395939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
    Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between obesity and B-type natriuretic peptide levels.
    McCord J; Mundy BJ; Hudson MP; Maisel AS; Hollander JE; Abraham WT; Steg PG; Omland T; Knudsen CW; Sandberg KR; McCullough PA;
    Arch Intern Med; 2004 Nov; 164(20):2247-52. PubMed ID: 15534162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study.
    Sadlonova M; Meyer T; Binder L; Wachter R; Edelmann F; Herrmann-Lingen C
    Psychoneuroendocrinology; 2019 Mar; 101():272-277. PubMed ID: 30594111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity paradox in elderly patients with heart failure: analysis of nutritional status.
    Casas-Vara A; Santolaria F; Fernández-Bereciartúa A; González-Reimers E; García-Ochoa A; Martínez-Riera A
    Nutrition; 2012 Jun; 28(6):616-22. PubMed ID: 22261572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study.
    Ettema EM; Kuipers J; van Faassen M; Groen H; van Roon AM; Lefrandt JD; Westerhuis R; Kema IP; van Goor H; Gansevoort RT; Gaillard CAJM; Franssen CFM
    BMC Nephrol; 2018 Aug; 19(1):214. PubMed ID: 30134847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine vasopressin antagonism in heart failure: Current status and possible new directions.
    Goldsmith SR
    J Cardiol; 2019 Jul; 74(1):49-52. PubMed ID: 30904236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link?
    Braun N; Hoess C; Kutz A; Christ-Crain M; Thomann R; Henzen C; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2017 Jan; 33():304-310. PubMed ID: 27742103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.